Syra Health Corp. (SYRA)
After hours:
| Previous close | 1.2000 |
| Open | 1.1900 |
| Bid | 1.4200 x 100 |
| Ask | 1.5100 x 100 |
| Day's range | 1.1900 - 1.5000 |
| 52-week range | 0.8120 - 8.3700 |
| Volume | |
| Avg. volume | 2,031,185 |
| Market cap | 9.64M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Syra Health Presents Overdose Lifeline with Mental and Behavioral Health Solutions Award
Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today it has presented the nonprofit organization Overdose Lifeline with the inaugural Syra Health Mental and Behavioral Health Solutions Award.
- PR Newswire
Syra Health To Discuss First Quarter 2024 Financial Results
Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it will report financial results for its first quarter 2024 ended March 31, 2024, on Thursday, May 9, 2024, before the market opens. The Company has scheduled a conference call that same day, May 9, 2024, at 9:00 a.m. ET, to review the results.
- PR Newswire
Syra Health Wins Award to Develop Health Equity Accelerator Plan for the City of Portland in Maine
Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it has been selected by the City of Portland in Maine for developing a health equity accelerator plan to address social determinants of health within the Greater Portland community. The purpose of the plan is to accelerate improvements in chronic disease outcomes among individuals ex
